A multiple drug-resistant Streptococcus pneumoniae of serotype 15A occurring from serotype 19A by capsular switching

T Savinova1, E Brzhozovskaya1, D Shagin2

  • 1National Medical Research Center for Children's Health, Lomonosovskiy av., 2a, Moscow, Russia.

Vaccine
|June 23, 2020
PubMed

Insights

A new multidrug-resistant Streptococcus pneumoniae strain emerged through capsular switching. This discovery highlights the need for ongoing surveillance of pneumococcal serotype and genotype structures to track resistant strains.

Area of Science:

  • Microbiology
  • Genetics
  • Epidemiology

Background:

  • Streptococcus pneumoniae is a significant human pathogen.
  • Pneumococci exhibit high genetic recombination, facilitating adaptation to medical treatments.
  • Acquisition of foreign DNA is a key evolutionary driver for this bacterium.

Purpose of the Study:

  • To investigate the genetic mechanisms behind the emergence of drug-resistant pneumococcal strains.
  • To identify novel serotypes and genotypes of multidrug-resistant Streptococcus pneumoniae.
  • To assess the evolutionary dynamics of pneumococcal adaptation to antibiotics and vaccines.

Main Methods:

  • Whole genome sequencing was employed to analyze the genetic makeup of the identified pneumococcal isolate.
  • Comparative genomic analysis was performed to identify genetic alterations, including capsular switching.
  • Phylogenetic analysis was used to trace the evolutionary origin of the resistant strain.

Main Results:

  • A multidrug-resistant serotype 15A Streptococcus pneumoniae strain was identified.
  • This strain resulted from capsular switching, originating from a serotype 19A/ST276 lineage.
  • The findings indicate the successful emergence and potential dissemination of recombinant, drug-resistant pneumococci with non-vaccine serotypes.

Conclusions:

  • Capsular switching is a significant mechanism for the emergence of multidrug-resistant Streptococcus pneumoniae.
  • The spread of these recombinant, non-vaccine type strains poses a public health concern.
  • Continuous monitoring of pneumococcal serotype and genotype is crucial for effective disease control and public health strategies.

Related Concept Videos

Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Streptococcal Pharyngitis01:27

Streptococcal Pharyngitis

Streptococcal pharyngitis, commonly known as “strep throat,” is an acute infection of the oropharyngeal tissues caused by the Gram‑positive Group A Streptococcus (Streptococcus pyogenes). Transmission occurs primarily through respiratory droplets expelled during coughing, sneezing, or talking.Mechanisms of Host Entry and Immune EvasionUpon entering the host, S. pyogenes adheres to the mucosal epithelial cells of the pharynx via surface proteins, notably lipoteichoic acid and the antiphagocytic...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...